RVNC – Revance Therapeutics, Inc.
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Fair Value
Margin Of Safety %
Put/Call OI Ratio
0.75
Float Short %
8.03
EPS 1 Diff
0.14
EPS Year Diff
2.42
Ticker: RVNC
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-09-06 | RVNC | 6.57 | 0.46 | 0.08 | 29733 |
| 2024-09-09 | RVNC | 6.59 | 0.46 | 0.50 | 29733 |
| 2024-09-10 | RVNC | 6.57 | 0.46 | 0.86 | 29733 |
| 2024-09-11 | RVNC | 6.58 | 0.46 | 0.00 | 29765 |
| 2024-09-12 | RVNC | 6.55 | 0.46 | 0.00 | 29786 |
| 2024-09-13 | RVNC | 6.55 | 0.45 | 999.99 | 30050 |
| 2024-09-16 | RVNC | 5.97 | 0.45 | 1.91 | 30055 |
| 2024-09-17 | RVNC | 5.97 | 0.67 | 0.18 | 42917 |
| 2024-09-18 | RVNC | 5.98 | 0.64 | 0.54 | 43753 |
| 2024-09-19 | RVNC | 5.86 | 0.60 | 11.76 | 44431 |
| 2024-09-20 | RVNC | 5.83 | 0.61 | 0.94 | 44939 |
| 2024-09-23 | RVNC | 5.36 | 0.56 | 60.42 | 36427 |
| 2024-09-24 | RVNC | 5.49 | 0.72 | 3.75 | 40132 |
| 2024-09-25 | RVNC | 5.3 | 0.72 | 1.01 | 40049 |
| 2024-09-26 | RVNC | 5.39 | 0.72 | 4.52 | 39908 |
| 2024-09-27 | RVNC | 5.36 | 0.72 | 37.38 | 40082 |
| 2024-09-30 | RVNC | 5.2 | 0.74 | 37.05 | 40300 |
| 2024-10-01 | RVNC | 5.2 | 0.75 | 67.00 | 40602 |
| 2024-10-02 | RVNC | 5.2 | 0.75 | 2.15 | 40709 |
| 2024-10-03 | RVNC | 5.26 | 0.75 | 48.00 | 40665 |
| 2024-10-04 | RVNC | 5.21 | 0.75 | 0.02 | 40682 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-09-06 | RVNC | 6.58 | 76.7 | - | -1.41 |
| 2024-09-09 | RVNC | 6.59 | 76.7 | - | -1.41 |
| 2024-09-10 | RVNC | 6.57 | 76.7 | - | -1.41 |
| 2024-09-11 | RVNC | 6.58 | 76.7 | - | -1.41 |
| 2024-09-12 | RVNC | 6.55 | 76.7 | - | -1.41 |
| 2024-09-13 | RVNC | 6.55 | 76.7 | - | -1.41 |
| 2024-09-16 | RVNC | 5.97 | 76.7 | - | -1.41 |
| 2024-09-17 | RVNC | 5.99 | 76.7 | - | -1.41 |
| 2024-09-18 | RVNC | 5.98 | 76.7 | - | -1.41 |
| 2024-09-19 | RVNC | 5.85 | 76.7 | - | -1.41 |
| 2024-09-20 | RVNC | 5.83 | 76.7 | - | -1.41 |
| 2024-09-23 | RVNC | 5.36 | 76.7 | - | -1.41 |
| 2024-09-24 | RVNC | 5.49 | 76.7 | - | -1.41 |
| 2024-09-25 | RVNC | 5.30 | 76.7 | - | -1.41 |
| 2024-09-26 | RVNC | 5.39 | 76.7 | - | -1.41 |
| 2024-09-27 | RVNC | 5.36 | 76.7 | - | -1.41 |
| 2024-09-30 | RVNC | 5.20 | 76.7 | - | -1.41 |
| 2024-10-01 | RVNC | 5.20 | 76.7 | - | -1.41 |
| 2024-10-02 | RVNC | 5.20 | 76.7 | - | -1.41 |
| 2024-10-03 | RVNC | 5.25 | 76.7 | - | -1.41 |
| 2024-10-04 | RVNC | 5.21 | 76.7 | - | -1.41 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-09-06 | RVNC | 0.01 | 13.79 | 9.74 |
| 2024-09-09 | RVNC | -0.32 | 13.79 | 9.74 |
| 2024-09-10 | RVNC | -0.32 | 13.79 | 9.74 |
| 2024-09-11 | RVNC | -0.32 | 13.79 | 9.74 |
| 2024-09-12 | RVNC | -0.32 | 13.79 | 7.95 |
| 2024-09-13 | RVNC | -0.32 | 13.79 | 7.95 |
| 2024-09-16 | RVNC | -0.32 | 13.79 | 7.95 |
| 2024-09-17 | RVNC | -0.32 | 13.79 | 7.95 |
| 2024-09-18 | RVNC | -0.32 | 13.79 | 7.95 |
| 2024-09-19 | RVNC | -0.32 | 13.79 | 7.95 |
| 2024-09-20 | RVNC | -0.03 | 13.79 | 7.95 |
| 2024-09-23 | RVNC | -0.03 | 13.79 | 7.95 |
| 2024-09-24 | RVNC | -0.03 | 13.79 | 7.95 |
| 2024-09-25 | RVNC | -0.03 | 13.79 | 8.03 |
| 2024-09-26 | RVNC | -0.03 | 13.79 | 8.03 |
| 2024-09-27 | RVNC | -0.03 | 13.79 | 8.03 |
| 2024-09-30 | RVNC | -0.03 | 13.79 | 8.03 |
| 2024-10-01 | RVNC | -0.03 | 13.79 | 8.03 |
| 2024-10-02 | RVNC | -0.03 | 13.79 | 8.03 |
| 2024-10-03 | RVNC | -0.03 | 13.79 | 8.03 |
| 2024-10-04 | RVNC | -0.03 | 13.79 | 8.03 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.36
Avg. EPS Est. Current Quarter
-0.38
Avg. EPS Est. Next Quarter
-0.22
Insider Transactions
-0.03
Institutional Transactions
13.79
Beta
0.97
Average Sales Estimate Current Quarter
68
Average Sales Estimate Next Quarter
88
Fair Value (Academic)
Quality Score
25
Growth Score
55
Sentiment Score
18
Actual DrawDown %
86.3
Max Drawdown 5-Year %
-93.8
Target Price
9.66
P/E
Forward P/E
PEG
P/S
2.23
P/B
P/Free Cash Flow
EPS
-3.19
Average EPS Est. Cur. Y
-1.41
EPS Next Y. (Est.)
-0.65
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-117.88
Relative Volume
0.53
Return on Equity vs Sector %
200.3
Return on Equity vs Industry %
179.1
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
stock quote shares RVNC – Revance Therapeutics, Inc. Stock Price stock today
news today RVNC – Revance Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RVNC – Revance Therapeutics, Inc. yahoo finance google finance
stock history RVNC – Revance Therapeutics, Inc. invest stock market
stock prices RVNC premarket after hours
ticker RVNC fair value insiders trading